Cargando…
Ocrelizumab: Prolonged severe acute respiratory syndrome Coronavirus-2 infection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990558/ http://dx.doi.org/10.1007/s40278-022-13065-y |
Ejemplares similares
-
Ocrelizumab: Coronavirus disease-2019 : 15 case reports
Publicado: (2022) -
Anti-severe acute respiratory syndrome coronavirus-2 antibody responses following Pfizer-BioNTech vaccination in a patient with multiple sclerosis treated with ocrelizumab: a case report
por: Mado, Hubert, et al.
Publicado: (2021) -
Fingolimod: Severe acute respiratory syndrome coronavirus-2 infection: case report
Publicado: (2020) -
Immunosuppressants: Severe acute respiratory syndrome coronavirus-2 infection: case report
Publicado: (2021) -
Multiple drugs: Prolongation of the clinical course in severe acute respiratory syndrome coronavirus 2 infection and off label use : case report
Publicado: (2020)